SAVA going it alone is contrary to what Remi has said over the years and I am in total agreement.
A BP partnership with upfront sizeable $ gives the staff the means to continue developing with SavaDX first on the list, followed by other neuros, cancer, whatever has been sitting on back burners.
Following a partnership (incl ? worldwide, Japan, EU, Australia, etc), the revenue become so enormous, that competition for takeover becomes almost obvious.
I can hope that the prescription is around $10k/yr to get everyone clamoring from Medicare, EMA, etc and nail the coffin on the pseudo brain bleed treatments.
I have pegged my exit SP at $300 and anything above is gravy .... only hope is that buyout isn't too early and we get shafted for a quick buck. Don't think rival bidders would let this gold mine pass them up so easily.
BTW, Manny was the unnamed part of the JS quad interview two years ago, along with Hillary's dad who I believe passed from "old age" after 3 years treatment. Not sure what happened to the 5 orig OL patients that showed 50% cogs improvement at one year and were from 5 diff locations. Doc "Doug" had known and reported on two orig OL, and I believe he posted on this forum before and would like to hear from him again. |
